Nausea is the most common early symptom, affecting approximately 2530% of users in the first week
Victoza (liraglutide) is another injectable GLP-1 agonist approved for type 2 diabetes, but it needs to be injected once a day instead of once a week because it doesnt stay in the body as long as Mounjaro and other alternatives
The standard progression moves through 5mg, 7.5mg, 10mg, 12.5mg and 15mg, with four weeks at each level before considering an increase
As of December 31, 2024
Second, PVN innervates the pituitary (PIT) portal system to achieve neuroendocrine regulatory effects [47, 48]
Semaglutide is a treatment that can offer long-term results, so it only makes sense that the treatment is long term, too